Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - buspirone hydrochloride - oral tablet - 5mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - buspirone hydrochloride - oral tablet - 10mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - buspirone hydrochloride - oral tablet - 5mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - buspirone hydrochloride - oral tablet - 10mg

Pietų Afrika - anglų - South African Health Products Regulatory Authority (SAHPRA)

bm_squib -

Airija - anglų - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - buspirone hydrochloride - tablets - 5 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - buspirone hydrochloride - tablets - 10 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - buspirone hydrochloride - tablets - 10 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - buspirone hydrochloride - tablets - 5 milligram

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

direct rx - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 5 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual du